Submit Deal

Reshma Kewalramani

CEO, President & Board Member at VERTEX PHARMACEUTICALS INC

Manager

Deal Bio

Total Deals3

Valued Deals3

Total Value£ 4.18 B

Avg. Deal Size£ 1.39 B

Market Context

Sort

Target: CATALYST BIOSCIENCES (PROTEASE MEDICINE PORTFOLIO)

Bidder: VERTEX PHARMACEUTICALS INC

5 Service Providers

5 Dealmakers

£ 48 M

Value

Target: VIACYTE

Bidder: VERTEX PHARMACEUTICALS INC

5 Service Providers

42 Dealmakers

£ 265 M

Value

Target: ALPINE IMMUNE SCIENCES INC

Bidder: VERTEX PHARMACEUTICALS INC

8 Service Providers

58 Dealmakers

£ 3.87 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy